This site is intended for healthcare professionals
News

Refusal to File letter for idecabtagene vicleucel for patients with heavily pre-treated relapsed and refractory multiple myeloma. BMS + bluebird bio

Read time: 1 mins
Last updated:28th Jun 2021
Published:14th May 2020
Condition: Multiple Myeloma
Type: drug
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest